Demographic characteristics | DTG/3TC/TDF (group I) n = 20 | DTG/ABT (group II) n = 24 | BIC/TAF/FTC (group III) n = 22 |
---|---|---|---|
Sex | |||
Male | 13 | 18 | 8 |
Female | 7 | 6 | 14 |
Age (yeras) | 61.5 (44–74) | 60.04 (45–85) | 54.27 (33–74) |
BMI (kg/m2) | 23.37 (18.37–28.23) | 22.74 (17.97–26.81) | 23.73 (18.03–25.30) |
TNM stage | |||
II | 14 | 10 | 18 |
III | 6 | 14 | 4 |
Differentiation | |||
Well differentiated | 0 | 3 | 2 |
Moderately differentiated | 15 | 14 | 16 |
Poorly differentiated | 5 | 7 | 4 |
Baseline CD4 count (cells/ul) | 368.35 (195–980) | 272.71 (83–757) | 315.14 (85–980) |
CD4/CD8 ratio | 0.91 (0.19–2.87) | 0.75 (0.14–2.86) | 0.60 (0.08–1.68) |
Type of cancer | |||
Rectal | 6 | 11 | 4 |
Colon | 14 | 13 | 18 |
Comorbidities | |||
Hypertension | 2 | 1 | 2 |
Diabetes mellitus | 4 | 1 | 3 |
HBV | 1 | 1 | 1 |
HCV | 1 | 2 | 0 |
Type of surgery | |||
Right hemicolectomy | 3 | 9 | 6 |
Left hemicolectomy | 5 | 1 | 4 |
Sigmoidectomy | 6 | 3 | 8 |
Low anterior resection | 6 | 11 | 4 |
Baseline HIV viral load (copies/ml) | |||
≤ 20 | 18 | 19 | 17 |
20–1000 | 1 | 1 | 2 |
> 1000 | 1 | 4 | 3 |
Chemotherapy regimen | |||
CapeOX | 16 | 19 | 22 |
mFolfox6 | 4 | 5 | 0 |
Untreated patients | 1 | 4 | 3 |
Pretreated patients | 19 | 20 | 19 |